X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/iaso-bio-announces-us-fda-approval-of-investigational-new-drug-application-for-bcma-car-t-equecabtagene-autoleucel-for-generalized-myasthenia-gravis-302107854.html
https://www.prnewswire.com/news-releases/iaso-bio-announces-nmpas-ind-approval-for-equecabtagene-autoleucel-in-second--and-third-line-treatment-of-multiple-myeloma-302103455.html
https://www.prnewswire.com/news-releases/iaso-bio-announces-new-development-partnership-with-umoja-biopharma-to-develop-ex-vivo-and-in-vivo-cell-and-gene-therapies-302025270.html
https://www.prnewswire.com/news-releases/iaso-bio-and-innovent-present-new-data-of-fucaso-equecabtagene-autoleucel-for-multiple-myeloma-patients-in-oral-presentation-at-ash-2023-302011244.html
https://www.prnewswire.com/news-releases/innovent-and-iaso-bio-present-updated-long-term-follow-up-data-for-bcma-car-t-fucaso-equecabtagene-autoleucel-at-ims-2023-301941923.html
https://www.prnewswire.com/news-releases/iaso-bio-presents-updated-long-term-follow-up-data-for-bcma-car-t-fucaso-equecabtagene-autoleucel-at-ims-2023-301941577.html
https://endpts.com/china-approves-first-bcma-car-t-therapy-from-innovent-iaso-bio/
https://www.prnewswire.com/news-releases/iaso-bio-and-innovent-announce-the-nmpa-approval-of-the-new-drug-application-for-equecabtagene-autoleucel-the-worlds-first-fully-human-bcma-car-t-therapy-for-the-treatment-of-relapsed-andor-refractory-multiple-myeloma-301868617.html
https://www.prnewswire.com/news-releases/iaso-bio-receives-fda-approval-of-ind-application-for-iaso-782-for-treatment-of-autoimmune-disease-301853662.html
Market Place
Share 
